216 related articles for article (PubMed ID: 27014907)
1. Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1.
Spans L; Van den Broeck T; Smeets E; Prekovic S; Thienpont B; Lambrechts D; Karnes RJ; Erho N; Alshalalfa M; Davicioni E; Helsen C; Gevaert T; Tosco L; Haustermans K; Lerut E; Joniau S; Claessens F
Oncotarget; 2016 Apr; 7(17):24326-38. PubMed ID: 27014907
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.
Wang K; Chen Z; Shi J; Feng Y; Yu M; Sun Y; Zhuang Q; Liang B; Luo G; Xu X; Fan M
Prostate; 2020 Sep; 80(12):977-985. PubMed ID: 32542727
[TBL] [Abstract][Full Text] [Related]
3. Tracing TET1 expression in prostate cancer: discovery of malignant cells with a distinct oncogenic signature.
Schagdarsurengin U; Luo C; Slanina H; Sheridan D; Füssel S; Böğürcü-Seidel N; Gattenloehner S; Baretton GB; Hofbauer LC; Wagenlehner F; Dansranjav T
Clin Epigenetics; 2021 Nov; 13(1):211. PubMed ID: 34844636
[TBL] [Abstract][Full Text] [Related]
4. Association of TET1 expression with colorectal cancer progression.
Tian Y; Pan F; Sun X; Gan M; Lin A; Zhang D; Zhu Y; Lai M
Scand J Gastroenterol; 2017 Mar; 52(3):312-320. PubMed ID: 27846738
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma.
Stasik S; Juratli TA; Petzold A; Richter S; Zolal A; Schackert G; Dahl A; Krex D; Thiede C
Neoplasia; 2020 Dec; 22(12):800-808. PubMed ID: 33142244
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of DNA epigenetic modulators during prostate carcinogenesis in an eastern Indian patient population: Prognostic implications.
Banerjee A; Bardhan A; Sarkar P; Datta C; Pal DK; Saha A; Ghosh A
Pathol Res Pract; 2024 Jan; 253():154970. PubMed ID: 38056136
[TBL] [Abstract][Full Text] [Related]
7. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases.
Hsu CH; Peng KL; Kang ML; Chen YR; Yang YC; Tsai CH; Chu CS; Jeng YM; Chen YT; Lin FM; Huang HD; Lu YY; Teng YC; Lin ST; Lin RK; Tang FM; Lee SB; Hsu HM; Yu JC; Hsiao PW; Juan LJ
Cell Rep; 2012 Sep; 2(3):568-79. PubMed ID: 22999938
[TBL] [Abstract][Full Text] [Related]
8. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
[TBL] [Abstract][Full Text] [Related]
9. Ten-eleven translocation 1 (TET1) gene is a potential target of miR-21-5p in human colorectal cancer.
Cheng YW; Chou CJ; Yang PM
Surg Oncol; 2018 Mar; 27(1):76-81. PubMed ID: 29549908
[TBL] [Abstract][Full Text] [Related]
10. TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma.
Shirai K; Nagae G; Seki M; Kudo Y; Kamio A; Hayashi A; Okabe A; Ota S; Tsutsumi S; Fujita T; Yamamoto S; Nakaki R; Kanki Y; Osawa T; Midorikawa Y; Tateishi K; Ichinose M; Aburatani H
Cancer Sci; 2021 Jul; 112(7):2855-2869. PubMed ID: 33970549
[TBL] [Abstract][Full Text] [Related]
11. Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers.
Wu HX; Chen YX; Wang ZX; Zhao Q; He MM; Wang YN; Wang F; Xu RH
J Immunother Cancer; 2019 Oct; 7(1):264. PubMed ID: 31623662
[TBL] [Abstract][Full Text] [Related]
12. High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.
Wang J; Li F; Ma Z; Yu M; Guo Q; Huang J; Yu W; Wang Y; Jin J
EBioMedicine; 2018 Feb; 28():90-96. PubMed ID: 29402726
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of intestinal stem cells by Tet1-mediated DNA hydroxymethylation.
Kim R; Sheaffer KL; Choi I; Won KJ; Kaestner KH
Genes Dev; 2016 Nov; 30(21):2433-2442. PubMed ID: 27856615
[TBL] [Abstract][Full Text] [Related]
14. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
[TBL] [Abstract][Full Text] [Related]
15. CagA increases DNA methylation and decreases PTEN expression in human gastric cancer.
Zhang B; Zhang X; Jin M; Hu L; Zang M; Qiu W; Wang S; Liu B; Liu S; Guo D
Mol Med Rep; 2019 Jan; 19(1):309-319. PubMed ID: 30431097
[TBL] [Abstract][Full Text] [Related]
16. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
17. Ten-eleven translocation 1 functions as a mediator of SOD3 expression in human lung cancer A549 cells.
Kamiya T; Nakahara R; Mori N; Hara H; Adachi T
Free Radic Res; 2017 Mar; 51(3):329-336. PubMed ID: 28351182
[TBL] [Abstract][Full Text] [Related]
18. Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells.
Wang W; Li X; Wang F; Sun XY
J Cell Biochem; 2018 Jan; 119(1):723-735. PubMed ID: 28643947
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of TET1 mediated hydroxymethylation of base excision repair pathway during lung carcinogenesis.
Chen HQ; Chen DJ; Li Y; Yuan WB; Fan J; Zhang Z; Han F; Jiang X; Chen JP; Wang DD; Cao J; Liu JY; Liu WB
Environ Pollut; 2021 Jan; 268(Pt B):115860. PubMed ID: 33120142
[TBL] [Abstract][Full Text] [Related]
20. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
